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Abstract
Background: The mechanism for hip pain has been unclear because of a lack of experimental animal models. We
aimed to establish an intra-articular injection technique to the rat hip and to document the effect of intra-articular
mono-iodoacetate (MIA) injection to the rat hip with radiography and histology.
Methods: Using 60 6-week-old male Sprague Dawley rats, 25 μl of sterile saline (control group; n = 30) and 25 μl of
sterile saline with 2 mg of MIA (MIA group; n = 30) was injected into the right hip joints via posterior approach using a
27G needle. The animals were examined with X-ray and histology 7, 14, 28, 42, and 56 days later (MIA group [n = 6]
and control group [n = 6], respectively).
Results: The MIA group showed progressive radiographic changes to the hip joint during the experimental period,
whereas the control group maintained a normal appearance. The microanatomic appearance was consistent with X-
ray images of progressive destruction in the MIA group and normal tissue in the control group. Osteoarthritic (OA)
changes became apparent at 42 and 56 days in the MIA group.
Conclusions: We established an intra-articular injection technique to the rat hip, creating a hip OA model in the rat by
intra-articular injection of MIA.
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Background
Osteoarthritis (OA) is the most common arthritis in
the elderly population [1]. Clinical signs of hip OA
are groin pain, restricted range of motion, and gait
disturbance [2, 3], which deteriorates the quality of
life. It is essential to understand how histologic
changes correlate with the onset of pain and joint de-
struction. OA is characterized by a progressive degen-
eration of articular cartilage [4, 5]. Increases of
mechanical stress and biochemical factors in the af-
fected joints are thought to be responsible for the
pathogenesis of OA. It has been suggested that tumor
necrosis factor α, interleukin-6, and calcitonin gene-
related peptide are up-regulated in OA [6, 7].
However, the mechanism for hip pain has been un-
clear because of a lack of experimental animal
models. For knee OA, several animal models have
been proposed, such as the anterior cruciate ligament
transection model [8], partial medial meniscectomy
model [9], or a combination of both [10]. Knee OA
can be chemically induced by intra-articular injection
of a metabolic inhibitor, mono-iodoacetate (MIA)
[11]. This compound inhibits the production of
glyceraldehyde-3-phosphate dehydrogenase by articu-
lar chondrocytes, leading to disruption of glycolytic
energy metabolism and synthetic processes, and even-
tually to cell death [12]. In knee MIA models using
rat and rabbit, cartilage lesions with loss of proteogly-
can matrix and chondrocyte death were induced in
the early phases of cartilage degeneration. With pro-
gressive cartilage deterioration, joint destruction with
exposed subchondral bone, pain and functional
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impairment were produced similar to human OA
[13]. However, to the best of our knowledge, intra-
articular MIA injection to the rat hip has not been
reported, partly because intra-articular injection to
the rat hip itself is technically demanding.
OA is diagnosed with radiographic findings [4]. Re-
cently an X-ray imaging unit for animal study has been
introduced as in vivo imager (Xtreme, Bruker, WI) [14].
This device is useful to evaluate morphological changes
of bone noninvasively without sacrificing the animal.
The purpose of this study was to establish an intra-
articular injection technique to the rat hip and to docu-
ment the effect of intra-articular MIA injection to the
rat hip using radiography and histology.
Methods
All protocols for animal procedures were reviewed and
approved by the ethics committee of our institution and
followed the National Institutes of Health Guidelines for
the Care and Use of Laboratory Animals.
Intra-articular injection technique to rat hip
To confirm the validity of intra-articular injection into the
hip, three male Sprague-Dawley (SD) rats weighing 200–
300 g at 6 weeks of age were prepared (CLEA, Tokyo,
Japan). All rats were anesthetized with an intraperitoneal
injection of sodium pentobarbital (40 mg/kg) and treated
aseptically throughout the experiments. A posterior ap-
proach was used to expose the right hip in the lateral de-
cubitus position. After removal of the hair, a 1.5–2.0 cm
skin incision was made in the direction of the posterior
line of the greater trochanter with the hip in neutral pos-
ition (Fig. 1a). The superficial gluteus muscle was identi-
fied and resected. Deeper than that, the obturator internus
and externus muscles, and the sciatic nerve, were identi-
fied. The obturator intermus and externus muscles were
detached from the greater trochanter. The posterior as-
pect of the capsule was exposed, protecting the sciatic
nerve. The joint space was identified by passive motion of
the limb (Fig. 1b). Then 25 μl of 1 % Pyoktanin Blue solu-
tion (Kishida Chemical Company, Osaka) was injected
into the joint using a 27G needle (Fig. 1c). We confirmed
that the pigment was not leaked and stayed within the
joint in all three rats (Fig. 1d). Thus we accepted this
intra-articular injection technique to the rat hip joint for
further study. The superficial gluteus muscle was sutured
and the skin was closed.
Rat MIA hip model
Thirty male SD rats were treated with a single intra-
articular injection of 2 mg of MIA (Sigma-Aldrich, St.
Louis, MO) in 25 μl of sterile saline (MIA group) and 30
Fig. 1 Intra-articular injection technique to rat hip. a The right hip is exposed via posterior approach in the lateral decubitus position. b The
posterior aspect of the capsule, the joint space (broken line), and the sciatic nerve (white arrow) are identified. c Intra-articular injection of 25 μl of
Pyoktanin Blue. d Leak test of the pigment
Miyamoto et al. BMC Musculoskeletal Disorders  (2016) 17:132 Page 2 of 7
were treated only with 25 μl of sterile saline (control
group) in their right hips. The doses of MIA were based
on previous literature that showed destruction of articu-
lar cartilage [15, 16]. The animals were examined 7, 14,
28, 42 and 56 days later (MIA group [n = 6] and control
group [n = 6], respectively).
X-ray imaging of the hip joint
After intraperitoneal anesthesia, the rats were laid in the
supine position with 0° of hip flexion, abduction, and in-
ternal and external rotation. Both limbs were fixed on
the table with tape. Anteroposterior bilateral X-rays of
the hips were taken with an in vivo imager (Xtreme,
Bruker, WI) [14]. Lateral images also were taken in 45°
of flexion and abduction and 0° of internal and external
rotation. X-ray examination was performed 7, 14, 28, 42
and 56 days later (MIA group [n = 6] and control group
[n = 6], respectively).
X-ray images were classified based on the Kellgren and
Lawrence (KL) system [4] as grade 0 (none: no radio-
graphic features of OA), grade 1 (doubtful: doubtful joint
space narrowing [JSN] and possible osteophyte), grade 2
(minimal: the presence of definite osteophytes and pos-
sible JSN), grade 3 (moderate: multiple osteophytes, def-
inite JSN, sclerosis, possible bony deformity), and grade
4 (severe: large osteophytes, marked JSN, severe sclerosis
and definite bony deformity).
Tissue preparation
The rats then were perfused transcardially with 0.9 % sa-
line, followed by 500 ml of 4 % paraformaldehyde in
phosphate buffer fixative (0.1 M, pH 7.4). The soft tis-
sues around the right hip joint including cartilage, syno-
vium and capsule were resected. The resected limbs
were cut at midfemur and the center of the femoral head
immersed in buffered paraformaldehyde fixative at 4 °C
for 1 week. The specimens were continuously deminera-
lized in reagent K-CX (FALMA, Tokyo, Japan) for 30 h
and 5 % sodium sulphate for 16 h, followed by paraffin
embedding for subsequent coronal sectioning. The sam-
ples were serially sectioned in steps of 8 μm, and stained
using hematoxylin and eosin (H-E), Safranin O, and
Toluidine Blue, respectively.
Histopathological analysis
Specimens were randomly assigned identification num-
bers to blind investigators to group association, and
assessed by light microscopy. Semi-quantitative histo-
pathological grading was performed according to a
modified Mankin scoring system established for grading
OA changes [17]. Mankin scores normally consider five
characteristics: structure, chondrocyte number, chondro-
cyte clustering, proteoglycan content, and subchondral
bone plate and/or tidemark changes, including vascular
invasion into cartilage. Three sections from each sample
were scored by two different blinded observers, for a
maximum possible score of 14. Total points were classi-
fied as low (1–3 points), moderate (4–7 points), or high
(>8 points). Osteophytes were defined as outgrowths of
the bone and cartilage occurring at the joint margins.
Osteophytic regions were examined in sections stained
with either HE, Safranin O, or Toluidine blue stains. To
evaluate the incidence of osteophyte formation, total
osteophyte number from five sections 100 μm apart was
evaluated from each hip joint. The percent incidence of
osteophytes was calculated for each group. Images of ar-
ticular cartilage and subchondral bone were examined
using an Olympus fluorescence microscope (DP71,
Japan) with 4× objective lens.
Statistical analysis
Statistical significance between MIA and control groups
was calculated using one- way analysis of variance and
Fisher’s exact probability tests (SPSS 16.0 Chicago, IL,




The MIA group showed progressive changes to the hip
joint during the experimental period (Fig. 2), whereas
the control group maintained a normal appearance
(Fig. 3). Seven days post-injection, X-rays showed no evi-
dence of degeneration or narrowing of the joint space in
either MIA (Fig. 2a, b) or control groups (Fig. 3a, b).
Thus all hips were grade 0 in KL classification. By
14 days, the MIA group showed possible JSN and cystic
changes in the femoral head; one hip was grade 1 and
five hips were grade 2 in KL classification (Fig. 2e, f ). By
28 days, the MIA group showed definite JSN and de-
formity of the femoral head, evidenced by a flattened
epiphysis. The articular surface was irregular and incon-
gruent; two hips were grade 2 and four hips were grade
3 in KL classification (Fig. 2i, j). By 42 days, the MIA
group showed severely deformed femoral heads, bone at-
rophy and erosion in the acetabulum. The articular sur-
face became incongruent but the joint space was
maintained. One hip was grade 3 and five hips were
grade 4 in KL classification (Fig. 2m, n). By 56 days, the
MIA group showed destructive changes of the femoral
head and subchondral bone of the acetabulum. All six
hips were grade 4 in KL classification (Fig. 2q, r).
Histopathological findings
Microanatomic appearance was consistent with X-ray
images with progressive destruction in the MIA group
(Fig. 2) and normal tissue in the control group (Fig. 3).
By day 7 post-injection, the MIA group showed an
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expanded synovial membrane by edema mixed with mild
to moderate infiltrates of lymphocytes, macrophages and
plasma cells (Fig. 2c, d). However, chondrocyte degener-
ation was absent both in the acetabulum and the femoral
head. The femoral head was spherical and the subchon-
dral bone was not involved. The mean Mankin score
was (Fig. 4) 0.3 (range, 0–1) in the MIA group and 0.2
(range, 0–1) in the control group, without a significant
difference (p = 0.549). The incidence of osteophytes was
0 % in both groups.
By 14 days, extensive collapse of the cartilaginous
matrix with marked loss of chondrocytes was noted in
the MIA group (Fig. 2g, h). The articular surface of the
femoral head became irregular. Focal areas of the sub-
chondral bone marrow were replaced by loosely ar-
ranged spindle cells contained within a fine stroma.
These areas of bone marrow replacement were marked
by the formation of cysts which were present underneath
damaged cartilage of the femoral head and were sharply
demarcated from normal trabecular bone and marrow
elements. The mean Mankin score (Fig. 4) was 5.0
(range, 4–8) in the MIA group and 0.8 (range, 0–2) in
the control group (p = 0.0002). The incidence of osteo-
phytes was one of six hips (17 %) in the MIA group and
none in the control group.
By 28 days, multifocal collapse of bony trabeculae in
the acetabulum and the femoral head were evident in
the MIA group (Fig. 2k, l). Osteophyte formation led to
capital drop of the flattened femoral head. Fragmented
bone was surrounded by numerous osteoclasts and was
contained within focally extensive areas of fibrosis that
replaced adjacent bone trabeculae and marrow elements.
Fig. 2 Time course of X-ray and histopathology of the hip in MIA group. After 7 days (a–d), 14 days (e–h), 28 days (i–l), 42 days (m–p), and 56 days
(q–t). Anteroposterior (a, e, i, m, and q) and lateral (b, f, j, n, and r) radiographs of the rat hip. Hematoxylin and eosin (c, g, k, o, and s) and Safranin O
(d, h, l, p, t) staining. Scale bars are 1 mm. This shows no evidence of narrowing of the joint space (a, b) or degeneration (c, d) at 7 days, but possible
joint space narrowing (e, f) and extensive involvement of cartilage (g, h) at 14 days, definite joint space narrowing and deformity of the femoral head
(i, j) and multifocal collapse of bony trabeculae in the acetabulum and the femoral head (k, l) at 28 days, severely deformed femoral head and erosive
acetabulum (m, n) and peeling of articular cartilage and exposure of subchondral bone (o, p) at 42 days, and destruction of the femoral head and
acetabulum (q, r) and complete disappearance of articular cartilage (s, t) at 56 days
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Small amounts of cellular debris also were present in
these areas. Gross lesions consisted of a well-demarcated
area of cartilage erosion both in the acetabulum and the
femoral head. The mean Mankin score (Fig. 4) was 8.5
(range, 7–10) in the MIA group and 2.0 (range, 1–3) in
the control group (p = 0.0001). The incidence of osteo-
phytes was two of six hips (33 %) in the MIA group and
none in the control group.
By 42 days, extensive areas of articular cartilage were
shed and disappeared in the MIA group (Fig. 2o, p).
Chondrocytes were shrunken with marked loss of chon-
drocyte cellular detail. There was multifocal collapse and
fragmentation of bony trabeculae, surrounded by epi-
physeal chondrocytes. The mean Mankin score (Fig. 4)
was 11.8 (range, 11–13) in the MIA group and 2.5
(range, 2–3) in the control group (p = 0.0001). The inci-
dence of osteophytes was three of six hips (50 %) in the
MIA group and none in the control group.
By 56 days, articular cartilage had disappeared com-
pletely in the MIA group (Fig. 2s, t). Chondrocytes were
Fig. 3 Time course of X-ray and histopathology of the hip in the control group. After 7 days (a–d), 14 days (e–h), 28 days (i–l), 42 days (m–p), and
56 days (q–t). Anteroposterior (a, e, i, m, and q) and lateral (b, f, j, n, and r) radiographs of the rat hip. Hematoxylin and eosin (c, g, k, o, and s) and
Safranin O (d, h, l, p, t) staining. Scale bars are 1 mm. This shows no evidence of degeneration or narrowing of the joint space during the period
Fig. 4 Mankin scores in the MIA and control groups. Osteoarthritic
changes become progressive in the MIA group in comparison with
controls after 14, 28, 42 and 56 days, respectively. *p <0.05
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fragmented and necrotic, and exposed to the articular
surface with a marked loss of height. Subchondral tra-
becular bone was partially exposed to the articular sur-
face. Bone remodeling of the trabecular bone was
present with bone resorption and active osteoclastic ac-
tivity. Cystic structures demarcated by fibrous tissue and
containing small amounts of necrotic debris were
present. The mean Mankin score (Fig. 4) was 12.7
(range, 11–14) in the MIA group and 2.7 (range, 2–3) in
the control group (p = 0.0001). The incidence of osteo-
phytes was three of six hips (50 %) in the MIA group
and none in the control group.
Discussion
This is the first study of a rat hip OA model induced by
intra-articular injection of MIA. The histological appear-
ance of MIA-injected hips showed an OA-like appear-
ance. The current study outlines the time-dependent
progression of histologic lesions in the rat hip with
major emphasis on subchondral bone as well as radio-
graphic changes. The intra-articular injection technique
to the rat hip using 25 μl of solution injected into the
joint using a 27G needle via a posterior approach in the
lateral decubitus position was shown to be reliable.
The time course for development of osteoarthritis after
MIA injection is of great interest. In our rat hip OA
model, articular cartilage degeneration became evident
14 days after MIA injection. By comparison, the intra-
articular MIA injection in the rat knee produced OA
changes within 7 days post-MIA [9, 18]. Guzman et al.
[18] had already observed extensive areas of chondrocyte
degeneration at 1 day and moderate collapse of the car-
tilaginous matrix with marked loss of chondrocyte by 5
or 7 days. Orita et al. [16] also reported OA change after
7 days. In the hip, we found that progression of the joint
destruction continued through 56 days post-MIA.
Ferreira-Gomes et al. reported time-dependent histo-
logical changes in the rat knee and a dose-dependent re-
sponse in the MIA model [19]. In that study, there was a
marked decrease of the thickness of the articular cartil-
age by 31 days with 0.3 mg of MIA; subchondral bone
became exposed with 1 mg; and thickening of the sub-
chondral bone was apparent with 2 mg [19]. In the
current study, such OA changes became apparent by 42
and 56 days with 2 mg of MIA injection into the rat hip.
It should be investigated whether time to cartilage de-
generation is different between the hip and the knee.
Radiological evaluation is a useful technique in animal
studies to analyze a joint lesion noninvasively and repeat-
edly. We succeeded in visualizing the anteroposterior and
lateral views of the rat hip with an in vivo imager, as one
would for human evaluations. In the current study, X-rays
showed a time-dependent progression of deformity of the
femoral head and the acetabulum consistent with
histopathology.
To our best knowledge, radiographic monitoring of
progressive osteoarthritis of the rat hip in addition to
histology has not been reported. We suggest that using
radiologic evaluation can reduce the unnecessary sacri-
fice of animals.
The cause and source of pain is uncertain in OA. Sen-
sory innervation of the hip in rats is distributed by the
L2, L3 and L4 dorsal root ganglia [20]. A novel rat
model of hip pain with intra-articular administration of
nerve growth factor produced inflammatory arthritis and
pain [21]. Animal models are essential to clarify the
source of hip pain. We believe that our rat MIA hip
model will contribute in the future to studies of the
source of the pain in hip OA.
There are several limitations to this study. First, it
should be confirmed which type of OA was induced in
the rat MIA hip model. MIA has been widely accepted
to induce OA in animal models [9, 16, 18]. This model
demonstrated characteristics of inflammatory arthritis
that was progressive. It involved rapidly destructive cox-
arthritis rather than chronic OA secondary to acetabular
dysplasia with insufficient acetabular coverage. Second,
JSN based on anteroposterior radiographs was not pre-
cise because the radiographs were taken in the supine
position without weight bearing. By definition, the KL
classification [4] is based on anteroposterior radiographs
during weight-bearing. This is difficult to accomplish in
an animal model. Thus we confirmed cartilage degener-
ation and JSN using histopathology. Third, we did not
study the dose-dependent response of MIA in the rat
hip as we only used a single 2 mg dose of MIA.
Effects of 0.3, 1 mg, or more of MIA, based on doses
used in previous studies, should also be investigated.
Fourth, young rats at 6 weeks of age instead of old were
applied because of relatively long-term study for rat until
56 days and because of adjustment to Orita’s study of knee
MIA model [16]. It is of great interest whether effect of
MIA shows age dependent progression or not. Fifth, this
study lacks analysis for pain transmitting substances in the
local tissues or dorsal root ganglia [20]. The level of in-
flammatory cytokines and their receptors, as well as
macrophage and endothelial cell markers, should be inves-
tigated quantitatively using protein determination or gene
expression. Sixth, behavioral testing is an essential part of
pain research [22, 23]. Further research employing func-
tional evaluations such as gait analysis are needed. Sev-
enth, quantitative assessment of bone remodeling using
micro-computed tomography, OA biomarkers, synovial
inflammation, immunohistochemical staining for cartilage
specific proteins, and cell death has not been investigated
yet, but they should be clarified for characteristics of rat
MIA hip model in the future.
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Conclusion
In conclusion, we established an intra-articular injection
technique to the rat hip using MIA that consistently
causes progressive hip OA.
Abbreviation
MIA: mono-iodoacetate; OA: osteoarthritis; JSN: joint space narrowing.
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